No Evidence for Association of Dopamine D2 Receptor Variant (Ser311/Cys311) with Major Psychosis

American Journal of Medical Genetics - Seminars in Medical Genetics

Volumn 67, Issue 4, 1996, Pages 415-417

  Sasaki, Tsukasa ^a   Macciardi, Fabio M ^a,c   Badri, Farideh ^a   Verga, Massimiliano ^c   Meltzer, Herbert Y ^d   Lieberman, Jeffrey ^e   Howard, Alfreda ^e   Bean, Graham ^a   Joffe, Russel T ^b   Hudson, Craig J ^a   Kennedy, James L ^a  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

^e ZUCKER HILLSIDE HOSPITAL   (United States)

Author keywords

Bipolar affective disorder; Delusional disorder; Dopamine D2 receptor; Genetics; Schizophrenia

Indexed keywords

DOPAMINE 2 RECEPTOR;

ALLELE; ARTICLE; CHROMOSOME VARIANT; DISEASE ASSOCIATION; FREQUENCY ANALYSIS; GENE FREQUENCY; GENOTYPE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PSYCHOSIS;

ADULT; AGE OF ONSET; AMINO ACID SEQUENCE; BIPOLAR DISORDER; CYSTEINE; DELUSIONS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHOTIC DISORDERS; RECEPTORS, DOPAMINE D2; REFERENCE VALUES; SCHIZOPHRENIA; SERINE; VARIATION (GENETICS);

EID: 0029841234     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19960726)67:4<415::AID-AJMG18>3.0.CO;2-M     Document Type: Article

References (11)

1. American Psychiatric Association (1987): "Diagnostic and Statistical Manual of Mental Disorders. 3rd Edition, Revised." Washington D.C.: American Psychiatric Association.
2. Andreasen NE (1982): Scale for the Assessment of Negative Symptoms (SANS). Iowa City: University of Iowa.
3. Arinami T, Itokawa M, Enguchi H, Tagaya H, Yano S, Shimizu H, Hamaguchi H, Toru M (1994): Association of dopamine D2 receptor molecular variant with schizophrenia. Lancet 343:703-704.
4. Arinami T, Itokawa M, Aoki J, Shibuya H, Ookubo Y, Iwawaki A, Ota K, Shimizu H, Hamaguchi H, Toru M (1996): Further association study on dopamine D2 receptor variant S311C in schizophrenia and affective disorders. Am J Med Genet (in press).
5. Asherson P, Williams N, Roberts E, McGuffin M, Owen M (1994): DRD2 Ser311/Cys311 polymorphism in schizophrenia. Lancet 343:1045.
6. Endicott J, Spitzer RL (1978): A diagnostic interview: The schedule for affective disorders and schizophrenia. Arch Gen Psychiat 35:837-844.
7. Hattori M, Nanko S, Dai XY, Fukuda R, Kazamatsuri H (1994): Mismatch PCR RFLP detection of DRD2 Ser311Cys polymorphism and schizophrenia. Biochem Biophys Res Commun 202:757-763.
8. Seeman P (1992): Dopamine receptor sequences. Neuropsychopharmacology 7:261-284.
9. Shaikh S, Collier D, Arranz M, Crocq M-A, Gill M, Kerwin R (1995): Examination of the DRD2 (Ser-Cys) variant in schizophrenia. Schizophr Res 15:48.
10. Sobell J, Sigurdson DC, Heston L, Sommer S (1994): S311C D2DR variant: No association with schizophrenia. Lancet 344:621-622.
11. Spitzer RL, Endicott J, Robins E (1977): "Research Diagnostic Criteria (RDC) for a Selected Group of Functional Disorders, 3rd Edition." New York: Biometrics Research.